Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 5/20 | 0.56 |
| ▸ | THRA | P10827 | 3/20 | 0.53 |
| ▸ | RARB | P10826 | 9/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | RARA | P10276 | 2/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.44 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.44 |
| ▸ | RARG | P13631 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19855164 | 0.91 | THRB (0.46) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19721952 | 0.90 | THRB (0.58) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19722398 | 0.90 | THRB (0.58) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19722533 | 0.89 | RARB (0.53) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19722229 | 0.88 | THRB (0.57) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19721939 | 0.86 | THRB (0.53) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19722103 | 0.86 | RARB (0.52) | THRBTHRARARBMAPTRARA | |
| SCHEMBL19721971 | 0.86 | THRB (0.57) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19721948 | 0.85 | THRB (0.51) | THRBTHRARARBALDH1A1MEN1 | |
| SCHEMBL19722497 | 0.85 | THRB (0.56) | THRBTHRARARBALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220128867-A1 | SUBSTRATE AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2022-04-28 | — | — | US | disclosed |
| US-11312906-B2 | Polymerizable monomer, liquid crystal composition using polymerizable monomer, and liquid crystal display device | DIC CORPORATION (JP) | 2022-04-26 | — | — | US | disclosed |
| US-20210223635-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2021-07-22 | — | — | US | disclosed |
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-20210171831-A1 | ALIGNMENT AID, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2021-06-10 | — | — | US | disclosed |
| US-20200224098-A1 | POLYMERIZABLE MONOMER, LIQUID CRYSTAL COMPOSITION USING POLYMERIZABLE MONOMER, AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2020-07-16 | — | — | US | disclosed |
| US-20200208054-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | DIC Corporation (Tokyo) (JP) | 2020-07-02 | — | — | US | disclosed |
| WO-2020008895-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT | DIC株式会社 | 2020-01-09 | — | — | WO | disclosed |
| EP-3257839-B1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| US-10392339-B2 | Polymerizable polar compound, liquid crystal composition, and liquid crystal display element | JNC CORPORATION (JP) | 2019-08-27 | — | — | US | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
| US-20170369418-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2017-12-28 | — | — | US | disclosed |
| EP-3257839-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2017-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10392339-B2 | Polymerizable polar compound, liquid crystal composition, and liquid crystal display element | SP1, HVCN1, CXCR1 | THRB 4606/4885THRA 4306/4885RARB 2607/4885 |
| US-20170369418-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, SPIN1, SAV1 | THRB 4233/4885THRA 3611/4885RARB 1568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.